High-dose dual antibiotic cement for hip hemiarthroplasty
This Bayesian re-analysis demonstrates that it is highly probable (> 90%) that there is at least some reduction of dSSI related to high-dose dual-antibiotic cement use when performing hemiarthroplasty; adding useful clinical nuance to the original trial findings in context of the noteworthy detrimental impact of dSSI in the study population. This study also highlights the potential benefits of a Bayesian approach to analysis due to improved interpretability of trial outcomes.
Authors
- Jemma Hudson (ORCID: https://orcid.org/0000-0002-6440-6419)
- Luke Farrow (ORCID: https://orcid.org/0000-0002-1443-5908)
- Mike Reed (ORCID: https://orcid.org/0000-0002-6309-2710)
- Alan M. George (ORCID: https://orcid.org/0000-0001-5017-4613)
- Marion Campbell (ORCID: https://orcid.org/0000-0001-5386-4097)
Institutions
- University of Aberdeen (GB)
- Aberdeen Royal Infirmary (GB)
- Northumbria Healthcare NHS Foundation Trust (GB)
- University of York (GB)
- University of Arkansas at Fayetteville (US)
Publication Details
- Journal
- The Bone & Joint Journal
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1302/0301-620x.107b9.bjj-2024-1364.r1
- Citations
- 2
- Primary Topic
- Orthopaedic implants and arthroplasty
- Type
- article
- Field-Weighted Citation Impact
- 4.01